RRML - OXA-48-Carbapenemase-Producing Klebsiella pneumoniae infections - the first cases diagnosed in Romanian National Institute of Infectious Diseases
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English


Journal Metrics

Impact Factor 0.493
Five Year Impact Factor 0.531
SNIP 0.373
JCI 0.17


Advanced search


Top 10 downloaded articles
- December 2022 -
 
Downregulation of hsa-miR-4328... 5
Normality assessment, few para... 4
High DNAJA4 expression correla... 4
Setting up an own laboratory p... 4
New Para-Clinical Investigatio... 3
Genetic risk factors for throm... 3
miR-190, CDK1, MCM10 and NDC80... 3
The relationship between matri... 2
A model for calculating measur... 2
The Use of Infrared Spectrosco... 2

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 25(1)/2017 DOI:10.1515/rrlm-2017-0006
XML
TXT

Short communication

OXA-48-Carbapenemase-Producing Klebsiella pneumoniae infections - the first cases diagnosed in Romanian National Institute of Infectious Diseases

Cristina Popescu, Gabriel Adrian Popescu, Olga Dorobăț, Alexandru Rafila, Diana Tănase, Claudia Mikula, Gudrun Weissensteiner, Steliana Huhulescu

Correspondence should be addressed to: Gabriel Adrian Popescu

Abstract:

We report first description of clinical cases of OXA-48 carbapenemase-producing Klebsiella pneumoniae originating from patients hospitalized in the most important Infectious Diseases Hospital from Romania, between December 2012 and March 2013. All strains were isolated from patients who were previously admitted in surgical wards. None of the patients had been admitted in a hospital outside of Romania.

Keywords: Klebsiella pneumoniae; OXA-48 carbapenemase;ESBL; risk factors for resistance

Received: 28.10.2016
Accepted: 14.1.2017
Published: 15.1.2017

 
  PDF Download full text PDF
(320 KB)
     
 
How to cite
Popescu C, Popescu GA, Dorobăț O, Rafila A, Tănase D, Mikula C, et al. OXA-48-Carbapenemase-Producing Klebsiella pneumoniae infections - the first cases diagnosed in Romanian National Institute of Infectious Diseases. Rev Romana Med Lab. 2017;25(1):55-61. DOI:10.1515/rrlm-2017-0006